Moneycontrol PRO
HomeNewsTrendsFlu virus strain in circulation causing more severe symptoms: Dr Gagandeep Kang

Flu virus strain in circulation causing more severe symptoms: Dr Gagandeep Kang

This particular H3N2 strain, which is behind most influenza cases in many cities, seems to be causing bronchitis and associated symptoms, such as diarrhoea and conjunctivitis. These symptoms are usually less common with influenza, says Kang.

March 06, 2023 / 10:35 IST

Top virologist Dr Gagandeep Kang is associated as a professor in the department of gastrointestinal sciences with the Christian Medical College (CMC) in Vellore, Tamil Nadu.  She has been a prominent scientific voice, simplifying the complex details around viral infections since the time COVID-19 took the world and India by storm.

In this chat with Moneycontrol, she explains why many cities in India are in the grip of a seasonal flu outbreak and the worries around the spread of avian influenza.

Edited excerpts:

Many cities in India are seeing a major surge in flu cases, with most people reporting more severe symptoms that are also long-lasting. What do you think are the reasons? Do we know enough? Does COVID-19 have any role to play, directly or indirectly?

There is a variation in severity among influenza strains, in addition to the variation in clinical presentations that come -- variations by age and previous exposure or vaccination.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

For example, in 2009, H1N1 was relatively mild with a high rate of asymptomatic infections, but in other outbreaks, it has been more severe. This particular H3N2 strain (of the Influenza A virus) seems to be causing more bronchitis as well as associated symptoms such as diarrhoea and conjunctivitis, which are somewhat less common, usually, with influenza.

This has nothing to do directly with SARS-CoV2. Indirectly, we could say that it might have something to do with COVID-19 because there was less intermingling of people for a couple of years, so there was less circulation of respiratory viruses than usual.

Once people start interacting again, influenza viruses have the opportunity to transmit at high rates again.

Also read: A lingering cough, occasional fever: All about the H3N2 flu sweeping across India

Is there something that can be done to mitigate the situation or do you think the influenza virus will run its course?

Influenza vaccines are available and we should be using them. I don't think healthy young people need annual vaccines, but the elderly should certainly take them. They are not the greatest vaccines, but in most seasons, they work. For the generally healthy, your bodies will handle the infection. Uncomplicated influenza needs only supportive therapy, such as cough medicine. Severe or complicated influenza, on the other hand, may benefit from neuraminidase inhibitors like Oseltamivir and adjunct therapy, including steroids.

Do you see a need to strengthen influenza and COVID-19 surveillance to assess viral infections in a better way?

Absolutely. The Indian Council of Medical Research (ICMR) has a network that is doing excellent respiratory virus surveillance and is planning to expand age groups where surveillance is done. Sustained surveillance of severe acute respiratory illness and milder influenza-like illness should be in place in all countries, as it is in India.

Perhaps some expansion for local data may be valuable in India, but we have a good sense of what is happening—this was not the case a few years ago.

The spread of the H5N1 variant of bird flu virus has triggered concerns in many parts of the world and recently its spillover to humans resulted in a girl’s death in Cambodia. Some scientists are saying that this virus now seems more adaptable for transmission into humans. Can bird flu virus emerge as a major threat globally in the near future?

Yes, this is a significant concern. Influenza A/H5 (H5N1) viruses have caused infrequent spillovers into humans since their emergence in 1997. There have been 870 reported human cases of A/H5 infection globally, which have resulted in over 450 deaths. This points to the high fatality rates. The ability of influenza viruses to cross species is the reason why public health authorities are so concerned about avian influenza.

While avian influenza is a serious illness and any zoonotic transmission is concerning, it is, as can be seen from the numbers, still rare in humans, and is typically linked to direct contact with infected birds or their droppings. No H5N1 avian influenza virus has been demonstrated to have had sustained human-to-human transmission.

Last month, the Ministry of Health, Cambodia, confirmed human influenza due to H5N1 and the patient died. Full genome virus sequence was available on GISAID (a global repository that provides open access to genomic data of influenza and SARS CoV viruses) three days back. The H5N1 virus, isolated from the cases in Cambodia, shows changes that were anticipated and have been found in previous avian and human strains when they go from a bird to a human. This does not indicate that the virus has mutated to become human-to-human transmissible. Therefore, waiting and watching very carefully is the appropriate strategy.

Also read: Influenza outbreak in several cities; patients report severe, longer sickness

Do you think India is better equipped to detect and respond quickly and adequately to future outbreaks of viral infections post COVID-19? If not, what may still be missing?

Yes, we are definitely better off now than we were before. We can and should maintain our surveillance structures, and also think about what we need to do beyond respiratory virus surveillance, to include other syndromes such as fevers, diarrhoea, hepatitis, etc.

Sumi Sukanya Dutta
Sumi Sukanya Dutta
first published: Mar 6, 2023 10:35 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347